NRSN · NeuroSense Therapeutics Ltd.
$0.59
-0.06 (-9.36%)
At close · Jul 24
Market Cap
$21.74M
Shares
36.10M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$11.13M
-9%
FY2025
Diluted EPS
-$0.44
+18.5%
FY2025
Operating Cash Flow
-$7.67M
+24.3%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| $6.23M | $5.7M | $7.27M | $5.59M | $1.39M | |
| $4.86M | $4.2M | $4.78M | $4.97M | $1.59M | |
| — | — | — | $77K | $19K | |
| -$11.09M | -$9.9M | -$12.05M | -$10.55M | -$2.99M | |
| -$40K | -$308K | $1.94M | $62K | -$235K | |
| -$11.13M | -$10.21M | -$10.11M | -$10.49M | -$3.22M | |
| USD/shares | -$0.44 | -$0.54 | -$0.74 | -$0.91 | -$0.52 |
| USD/shares | -$0.44 | -$0.54 | -$0.74 | -$0.91 | -$0.52 |
| shares | 25.48M | 18.6M | 13.64M | 11.5M | 6.24M |
| shares | 25.48M | 18.6M | 13.64M | 11.5M | — |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.